Veraxa Biotech AG - Post de-SPAC VRXA Revenue Breakdown

NASDAQ VRXA
$1.19 -0.06 (-4.80%)
At close: Oct 1, 2026 · 4:00 PM EDT
No revenue breakdown for VRXA Veraxa Biotech AG - Post de-SPAC does not report revenue split by segment, product or geography.